Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age.

Bekeredjian R, Krumsdorf U, Chorianopoulos E, Kallenbach K, Karck M, Katus HA, Rottbauer W.

Am J Cardiol. 2010 Dec 15;106(12):1777-81. doi: 10.1016/j.amjcard.2010.08.017. Epub 2010 Nov 4.

PMID:
21055715
2.

Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis.

Ussia GP, Barbanti M, Cammalleri V, Scarabelli M, Mulè M, Aruta P, Pistritto AM, Immè S, Capodanno D, Sarkar K, Gulino S, Tamburino C.

EuroIntervention. 2011 Sep;7(5):573-9. doi: 10.4244/EIJV7I5A93.

3.

Quality of life among patients undergoing transcatheter aortic valve implantation.

Krane M, Deutsch MA, Bleiziffer S, Schneider L, Ruge H, Mazzitelli D, Schreiber C, Brockmann G, Voss B, Bauernschmitt R, Lange R.

Am Heart J. 2010 Sep;160(3):451-7. doi: 10.1016/j.ahj.2010.05.038.

PMID:
20826252
4.

Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.

Kefer J, Beauloye C, Astarci P, Renkin J, Glineur D, Dekleermaeker A, Vanoverschelde JL.

Am J Cardiol. 2010 Dec 15;106(12):1782-6. doi: 10.1016/j.amjcard.2010.07.051. Epub 2010 Nov 4.

PMID:
21055712
5.

One-year results of health-related quality of life among patients undergoing transcatheter aortic valve implantation.

Krane M, Deutsch MA, Piazza N, Muhtarova T, Elhmidi Y, Mazzitelli D, Voss B, Ruge H, Badiu CC, Kornek M, Bleiziffer S, Lange R.

Am J Cardiol. 2012 Jun 15;109(12):1774-81. doi: 10.1016/j.amjcard.2012.02.021. Epub 2012 Apr 19.

PMID:
22520622
6.

Long-term quality of life improvement after transcatheter aortic valve implantation.

Georgiadou P, Kontodima P, Sbarouni E, Karavolias GK, Smirli A, Xanthos T, Troupis T, Khouri M, Papadimitriou L, Voudris V.

Am Heart J. 2011 Aug;162(2):232-7. doi: 10.1016/j.ahj.2011.06.004. Epub 2011 Jul 20.

PMID:
21835282
7.

One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis.

Gotzmann M, Bojara W, Lindstaedt M, Ewers A, Bösche L, Germing A, Lawo T, Bechtel M, Laczkovics A, Mügge A.

Am J Cardiol. 2011 Jun 1;107(11):1687-92. doi: 10.1016/j.amjcard.2011.01.058. Epub 2011 Mar 23.

PMID:
21439537
8.

Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.

Gotzmann M, Pljakic A, Bojara W, Lindstaedt M, Ewers A, Germing A, Mügge A.

Am Heart J. 2011 Aug;162(2):238-245.e1. doi: 10.1016/j.ahj.2011.05.011. Epub 2011 Jul 18.

PMID:
21835283
9.

Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates.

Taramasso M, Latib A, Cioni M, Denti P, Buzzatti N, Godino C, Chieffo A, Alfieri O, Colombo A, Maisano F.

EuroIntervention. 2012 Aug;8(4):429-36. doi: 10.4244/EIJV8I4A68.

10.

Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison.

Stöhr R, Dohmen G, Herpertz R, Brehmer K, Aktug O, Koos R, Altiok E, Stegemann E, Autschbach R, Marx N, Hoffmann R.

Coron Artery Dis. 2011 Dec;22(8):595-600. doi: 10.1097/MCA.0b013e32834d335e.

PMID:
22009042
11.

Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation.

Stortecky S, Schmid V, Windecker S, Kadner A, Pilgrim T, Buellesfeld L, Khattab AA, Wenaweser P.

EuroIntervention. 2012 Aug;8(4):437-43. doi: 10.4244/EIJV8I4A69.

12.

[Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement].

Zahn R, Schiele R, Kilkowski C, Klein B, Schwarz AK, Zeymer U, Lehmann A, Cornelius B, Horack M, Saggau W, Werling C.

Dtsch Med Wochenschr. 2010 Aug;135(33):1589-95. doi: 10.1055/s-0030-1262450. Epub 2010 Aug 17. German.

PMID:
20717862
13.

Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis.

Gotzmann M, Hehen T, Germing A, Lindstaedt M, Yazar A, Laczkovics A, Mumme A, Mügge A, Bojara W.

Heart. 2010 Jul;96(14):1102-6. doi: 10.1136/hrt.2009.180661. Epub 2009 Nov 1.

PMID:
19884109
14.

Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.

Ussia GP, Barbanti M, Petronio AS, Tarantini G, Ettori F, Colombo A, Violini R, Ramondo A, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, De Carlo M, Napodano M, Fiorina C, De Marco F, Antoniucci D, de Cillis E, Capodanno D, Tamburino C; CoreValve Italian Registry Investigators.

Eur Heart J. 2012 Apr;33(8):969-76. doi: 10.1093/eurheartj/ehr491. Epub 2012 Jan 12.

15.

Prognostic benefit of transcatheter aortic valve implantation compared with medical therapy in patients with inoperable aortic stenosis.

Rajani R, Buxton W, Haworth P, Khawaja MZ, Sohal M, Brum RL, Hutchinson N, de Belder A, Trivedi U, Hildick-Smith D.

Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1121-6. doi: 10.1002/ccd.22418.

PMID:
20146205
16.

Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.

Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R.

J Am Coll Cardiol. 2007 Jul 3;50(1):69-76. Epub 2007 Jun 6.

17.

Vascular access site complications after percutaneous transfemoral aortic valve implantation.

Kahlert P, Al-Rashid F, Weber M, Wendt D, Heine T, Kottenberg E, Thielmann M, Kühl H, Peters J, Jakob HG, Sack S, Erbel R, Eggebrecht H.

Herz. 2009 Aug;34(5):398-408. doi: 10.1007/s00059-009-3252-3.

PMID:
19711036
18.

Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation.

Ben-Dor I, Dvir D, Barbash IM, Okubagzi P, Torguson R, Xue Z, Lindsay J, Satler LF, Pichard AD, Waksman R.

Am J Cardiol. 2012 Oct 1;110(7):1008-14. doi: 10.1016/j.amjcard.2012.05.034. Epub 2012 Jun 19.

PMID:
22721576
19.

A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study.

Piazza N, van Gameren M, Jüni P, Wenaweser P, Carrel T, Onuma Y, Gahl B, Hellige G, Otten A, Kappetein AP, Takkenberg JJ, van Domburg R, de Jaegere P, Serruys PW, Windecker S.

EuroIntervention. 2009 Nov;5(5):580-8.

PMID:
20142179
20.

Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial).

Kodali SK, O'Neill WW, Moses JW, Williams M, Smith CR, Tuzcu M, Svensson LG, Kapadia S, Hanzel G, Kirtane AJ, Leon MB.

Am J Cardiol. 2011 Apr 1;107(7):1058-64. doi: 10.1016/j.amjcard.2010.11.034.

PMID:
21419887
Items per page

Supplemental Content

Write to the Help Desk